Search Results - "Boutis, A"

Diabetes mellitus secondary to treatment with immune checkpoint inhibitors by Venetsanaki, V, Boutis, A, Chrisoulidou, A, Papakotoulas, P

“…Cancer immunotherapy has been one of the highlights in the advancement of cancer care. Certain immune checkpoint inhibitors bind to PD-1 on T cells and mediate…”
Get full text

The peculiar dermatoscopic pattern of scalp melanoma by Spyridis, I., Papageorgiou, C., Apalla, Z., Manoli, S.M., Eftychidoy, P., Gkentsidi, T., Bobos, M., Boutis, A., Vakirlis, E., Sotiriou, E., Ioannides, D., Lallas, A.

“…Background Melanomas developing on anatomic sites other than the trunk and extremities have a special pathogenetic and mutational profile, morphologic…”
Get full text

Vaccine third dose and cancer patients: necessity or luxury? by Pappas, G., Saloustros, E., Boutis, A., Tsoukalas, N., Nikolaou, M., Christopoulou, A., Agelaki, S., Boukovinas, I., Ardavanis, A., Saridaki, Z.

“…The current state of the SARS-CoV-2 pandemic is an equilibrium between expanding vaccine coverage on the one hand, and emergence of variants of concern which…”
Get full text

Bleomycin cardiotoxicity during chemotherapy for an ovarian germ cell tumor by Didagelos, M, Boutis, A, Diamantopoulos, N, Sotiriadou, M, Fotiou, C

“…Platinum-based chemotherapeutic regimens, including BEP (bleomycin, etoposide, cisplatin) represent the standard of care, first line therapy in non-epithelial…”
Get full text

89P Tamoxifen versus aromatase inhibitors as adjuvant therapy in premenopausal women with hormone receptor-positive breast cancer: Effects on sexuality and the female reproductive system by Skolariki, A., Boutis, A., Kosmidis, E.K.

Get full text

Matrix metalloproteinases and proangiogenic factors in testicular germ cell tumors by Diamantopoulos, N, Boutis, A L, Koratzis, I, Andreadis, C, Galaktidou, G, Mouratidou, D, Kortsaris, A

“…Testicular cancer is the most frequent solid tumor in young male adults and a disease with elusive pathogenesis. The purpose of this study was to determine the…”
Get more information

Neurological findings in a case of coma secondary to Datura stramonium poisoning by Parissis, D., Mellidis, C., Boutis, A., Apostolidis, K., Ignatiadis, M., Kiosses, V., Milonas, I.

Get full text

Neoadjuvant chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy for larynx preservation in patients with advanced laryngeal cancer by Andreadis, C, Iliopoulou, C, Sidiras, T, Boutis, A, Diamantopoulos, N, Vahtsevanos, K, Gennatas, K, Mouratidou, D

“…The efficacy and toxicity of neoadjuvant chemotherapy followed by radiotherapy and concurrent chemoradiotherapy and their impact on larynx preservation have…”
Get more information

Real-world data on the safety and efficacy of trastuzumab deruxtecan and sacituzumab govitecan in patients with advanced breast cancer: the experience of the Hellenic Cooperative Oncology Group by Fountzilas, E., Lalla, T., Karakatsoulis, G., Papazisis, K., Exarchos, K., Koumarianou, A., Nikolaidi, A., Binas, I., Mauri, D., Karageorgopoulou, S., Razis, E., Christopoulou, A., Boutis, A., Douganiotis, G., Zagouri, F., Stamatopoulou, S., Spathas, N., Tryfonopoulos, D., Psyrri, A., Koutras, A.

Get full text

439P Testing HR+ / HER2- patients with advanced or metastatic breast cancer for identification of tissue mutations in the PIK3CA gene: Results of a national program by the Hellenic Society of Medical Oncology (HeSMO) by Boutis, A., Nikolaou, M., Ardavanis, A., Tolis, C., Loga, K., Korantzis, I., Koumarianou, A., Christopoulou, A.N., Papatsimpas, G., Bokas, A., Pliarchopoulou, K., Kampletsas, E., Kesisis, G., Biziota, E., Psianou, K., Karageorgopoulou, S., Sogka, E.A., Tsoukalas, N.G., Chatzifoti, N., Saridaki-Zoras, Z.

Get full text

1707P CureCancer digital tool in the routine clinical oncology practice facilitates PROs, communicating with HCPs, treatment adherence and “distancing interventions” during COVID-19 and reduces costs: A feasibility and satisfaction study by Galiti, D., Agelaki, S., Karampeazis, A., Linardou, H., Tsoukalas, N., Arvanitou, E., Georgopoulou, E., Vallilas, C., Syrigos, K., Sgourou, S., Kokkali-Zervos, S., Stamatogianni, E., Boutis, A., Christopoulou, A.N., Kontovinis, L., Mala, A., Rigas, G., Saridaki-Zoras, Z., Nicolatou-Galitis, O., Boukovinas, I.

Get full text

Economic evaluation of pazopanib as first-line treatment of metastatic renal cell carcinoma in Greece by Solakidi, A., Kourlaba, G., Kontovinis, L., Bournakis, E., Boutis, A., Koutsoukos, K., Syrios, J., Tzovaras, A., Chatzikou, M., Michailidi, C., Maniadakis, N.

Get full text

Economic Evaluation of Everolimus as Second-Line Treatment of Metastatic Renal Cell Carcinoma in Greece by Solakidi, A, Kourlaba, G, Kontovinis, L, Koutsoukos, K, Bournakis, E, Boutis, A, Syrios, J, Tzovaras, A, Michailidi, C, Kalogeropoulou, M, Maniadakis, N

Get full text

PCN132 - Economic Evaluation of Everolimus as Second-Line Treatment of Metastatic Renal Cell Carcinoma in Greece by Solakidi, A, Kourlaba, G, Kontovinis, L, Koutsoukos, K, Bournakis, E, Boutis, A, Syrios, J, Tzovaras, A, Michailidi, C, Kalogeropoulou, M, Maniadakis, N

Get full text

An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece by Mountzios, Giannis, Lampaki, Sofia, Koliou, Georgia-Angeliki, Vozikis, Athanassios, Kontogiorgos, Ioannis, Papantoniou, Panagiotis, Koufaki, Margarita-Ioanna, Res, Eleni, Boutis, Anastasios, Christopoulou, Athina, Pastelli, Nicoleta, Grivas, Anastasios, Aravantinos, Gerasimos, Lalla, Efthalia, Oikonomopoulos, Georgios, Koumarianou, Anna, Spyratos, Dionisios, Bafaloukos, Dimitrios, Rigakos, Georgios, Papakotoulas, Pavlos, Fountzilas, George, Linardou, Helena

“…Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the preferred first-line option for patients with advanced, EGFR-mutant non-small…”
Get full text

Serum CYFRA 21-1 in patients with invasive bladder cancer and its relevance as a tumor marker during chemotherapy by Andreadis, Charalampos, Touloupidis, Stavros, Galaktidou, Grammati, Kortsaris, Alexandros H, Boutis, Anastasios, Mouratidou, Despina

“…Previous studies have shown that serum levels of the degradation products of cytokeratins could be used as surrogate markers in the diagnosis and followup of…”
Get more information

Serum proangiogenic factors in patients with testicular germ cell tumors by Boutis, A. L., Diamantopoulos, N., Mouratidou, D., Andreadis, C., Galaktidou, G., Papazisis, K., Lalla, E., Kortsaris, A.

“…Abstract only…”
Get full text

Relationship between insulin-like growth factor-1 and human testicular cancer by Kortsaris, A. H., Diamantopoulos, N., Galaktidou, G., Andreadis, C., Boutis, A. L., Zavos, C., Mouratidou, D.

“…Abstract only 4586 Background: Insulin-like growth factor (IGF) has an established role in various types of cancer inducing cellular proliferation, possessing…”
Get full text

NSC 290205-based Therapy in Murine Pancreatic Adenocarcinoma PAN02 in Combination with Adriamycin (ADR) by PAPAGEORGIOU, Athanasios, ANDREADIS, Charalambos, BOUTIS, Anastasios, LIALIARIS, Theodoros S, MOURATIDOU, Despina

“…Background: NSC 290205 (A) is a hybrid synthetic antitumor ester, which combines a D-lactam derivative of androsterone and nitrogen mustard. In this study, the…”
Get full text

Sialyltransferase and nucleoside diphosphatase as markers for tumor monitoring by Papadopoulou-Boutis, A, Kortsaris, A, Boutis, L, Antonoglou, O, Karemfyllis, T, Mouratidou, D, Koukourikos, S, Trakatellis, A

“…In this study we report serum sialyltransferase and nucleoside diphosphatase activities of patients with malignant tumors of various primary sites and extent,…”
Get more information